Opioid analgesic and benzodiazepine sedative combination

This page covers all Opioid analgesic and benzodiazepine sedative combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Mu opioid receptor; GABA-A receptor.

Targets

Mu opioid receptor; GABA-A receptor

Marketed (1)

• Morphine and Midazolam · Ain Shams University · Pain management, Palliative care, Acute care sedation
  Morphine is an opioid agonist that binds mu opioid receptors to reduce pain perception, while midazolam is a benzodiazepine that enhances GABA inhibitory signaling to produce sedation and anxiolysis.

Patent intelligence

• opioid analgesic and benzodiazepine sedative combination patent landscape — aggregated cliff calendar, attackable patents, originator estates